Dacomitinib (PF-00299804) in Advanced/Metastatic Squamous Cell Carcinoma of the Penis

Conditions:   Penile Neoplasms;   Carcinoma, Squamous Cell
Intervention:   Drug: Dacomitinib
Sponsors:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   Pfizer
Recruiting - verified March 2017

http://ift.tt/2m6zbdf